176 related articles for article (PubMed ID: 22518117)
1. Development of screening tools for the interpretation of chemical biomonitoring data.
Becker RA; Hays SM; Robison S; Aylward LL
J Toxicol; 2012; 2012():941082. PubMed ID: 22518117
[TBL] [Abstract][Full Text] [Related]
2. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
Boogaard PJ; Hays SM; Aylward LL
Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
[TBL] [Abstract][Full Text] [Related]
3. Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH.
Boogaard PJ; Aylward LL; Hays SM
Int J Hyg Environ Health; 2012 Feb; 215(2):238-41. PubMed ID: 22177527
[TBL] [Abstract][Full Text] [Related]
4. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
[TBL] [Abstract][Full Text] [Related]
5. Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context.
Hays SM; Aylward LL
J Appl Toxicol; 2009 May; 29(4):275-88. PubMed ID: 19115313
[TBL] [Abstract][Full Text] [Related]
6. Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents.
Hays SM; Aylward LL
Int J Hyg Environ Health; 2012 Feb; 215(2):145-8. PubMed ID: 22192580
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.
Hays SM; Aylward LL; LaKind JS; Bartels MJ; Barton HA; Boogaard PJ; Brunk C; DiZio S; Dourson M; Goldstein DA; Lipscomb J; Kilpatrick ME; Krewski D; Krishnan K; Nordberg M; Okino M; Tan YM; Viau C; Yager JW;
Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S4-15. PubMed ID: 18583008
[TBL] [Abstract][Full Text] [Related]
8. Biomonitoring Equivalents for benzene.
Hays SM; Pyatt DW; Kirman CR; Aylward LL
Regul Toxicol Pharmacol; 2012 Feb; 62(1):62-73. PubMed ID: 22178585
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals.
Aylward LL; Kirman CR; Schoeny R; Portier CJ; Hays SM
Environ Health Perspect; 2013 Mar; 121(3):287-94. PubMed ID: 23232556
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of human biomonitoring data in a health risk based context: An updated analysis of population level data from the Canadian Health Measures Survey.
Faure S; Noisel N; Werry K; Karthikeyan S; Aylward LL; St-Amand A
Int J Hyg Environ Health; 2020 Jan; 223(1):267-280. PubMed ID: 31523017
[TBL] [Abstract][Full Text] [Related]
11. Physiologically based kinetic (PBK) modelling and human biomonitoring data for mixture risk assessment.
Pletz J; Blakeman S; Paini A; Parissis N; Worth A; Andersson AM; Frederiksen H; Sakhi AK; Thomsen C; Bopp SK
Environ Int; 2020 Oct; 143():105978. PubMed ID: 32763630
[TBL] [Abstract][Full Text] [Related]
12. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
Aylward LL; Kirman CR; Blount BC; Hays SM
Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
[TBL] [Abstract][Full Text] [Related]
13. Derivation of Biomonitoring Equivalents for aluminium for the interpretation of population-level biomonitoring data.
Poddalgoda D; Hays SM; Kirman C; Chander N; Nong A
Regul Toxicol Pharmacol; 2021 Jun; 122():104913. PubMed ID: 33652037
[TBL] [Abstract][Full Text] [Related]
14. Biomonitoring equivalents for DDT/DDE.
Kirman CR; Aylward LL; Hays SM; Krishnan K; Nong A
Regul Toxicol Pharmacol; 2011 Jul; 60(2):172-80. PubMed ID: 21466830
[TBL] [Abstract][Full Text] [Related]
15. Screening of population level biomonitoring data from the Canadian Health Measures Survey in a risk-based context.
St-Amand A; Werry K; Aylward LL; Hays SM; Nong A
Toxicol Lett; 2014 Dec; 231(2):126-34. PubMed ID: 25455445
[TBL] [Abstract][Full Text] [Related]
16. Biomonitoring Equivalents for glyphosate.
Hays SM; Kirman CR; Flippin J; Lopez T
Regul Toxicol Pharmacol; 2023 Oct; 144():105481. PubMed ID: 37633328
[TBL] [Abstract][Full Text] [Related]
17. A new method for generating distributions of biomonitoring equivalents to support exposure assessment and prioritization.
Phillips MB; Sobus JR; George BJ; Isaacs K; Conolly R; Tan YM
Regul Toxicol Pharmacol; 2014 Aug; 69(3):434-42. PubMed ID: 24845241
[TBL] [Abstract][Full Text] [Related]
18. Biomonitoring equivalents for 2,2',4,4',5-pentabromodiphenylether (PBDE-99).
Krishnan K; Adamou T; Aylward LL; Hays SM; Kirman CR; Nong A
Regul Toxicol Pharmacol; 2011 Jul; 60(2):165-71. PubMed ID: 21466829
[TBL] [Abstract][Full Text] [Related]
19. Deriving Biomonitoring Equivalents for selected E- and P-series glycol ethers for public health risk assessment.
Poet T; Ball N; Hays SM
Int J Hyg Environ Health; 2016 Jan; 219(1):88-100. PubMed ID: 26475513
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop.
LaKind JS; Aylward LL; Brunk C; DiZio S; Dourson M; Goldstein DA; Kilpatrick ME; Krewski D; Bartels MJ; Barton HA; Boogaard PJ; Lipscomb J; Krishnan K; Nordberg M; Okino M; Tan YM; Viau C; Yager JW; Hays SM;
Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S16-26. PubMed ID: 18579271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
